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Abstract
Background: Resveratrol and Berberis integerrima (B. integerrima) are known to be natural
antioxidants and regulators of human metabolism. However, the effects of resveratrol and B.
integerrima on the ovarian morphology in polycystic ovary syndrome (PCOS) are not obvious.
Objective: This study aimed to determine the effect of the hydroalcoholic extract of B.
integerrima in combination with resveratrol on some biochemical parameters and ovarian
morphology in the letrozole-induced PCOS rat.
Materials andMethods: Seventy adult female Sprague-Dawley rats aged 10-12 weeks weighing
200 ± 20 gr were randomly divided into seven groups (n = 10/each). Group I): normal; Group II):
vehicle; Group III): letrozole-induced PCOS 1 mg/kg letrozole orally, rats receiving 1 cc normal
saline orally; Group IV): PCOS + receiving 150 mg/kg metformin orally; Group V): PCOS +
receiving 20 mg/kg resveratrol orally; Group VI): PCOS + 3 gr/kg barberry orally; and Group VII):
PCOS + receiving 3 gr/kg barberry and 20 mg/kg resveratrol orally. All animals were followed-
up for 63 days. The biochemical parameters and histological assessments of ovaries were
performed.
Results: Resveratrol alone and/or in combination with B. integerrima treatment in rats led to
a significant decrease in low-density lipoprotein, triglyceride, malondialdehyde , and tumor
necrosis factor-alpha concentrations (p = 0.02). The groups IV, V, VI, and VII showed a decrease
in insulin resistance and an increase in the superoxide dismutase, total antioxidant capacity, and
high-density lipoprotein (p = 0.01). No significant difference was observed between the level of
serum glucose in the treatment groups. Number of cystic follicles had a significant decrease in
barberry, resveratrol, and their combination groups (p < 0.001).
Conclusion: Resveratrol, B. integerrima, and their combination as natural products with fewer
side effects might be effective as an alternative medicine in treatment of PCOS.
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1. Introduction
Polycystic ovary syndrome (PCOS) is one of
the most common endocrine disorders of fertility
in women that affects 6-14% of them during the
reproductive years. In the Iranian population, the
prevalence of PCOS has been reported to be 7.1%,
11.7%, and 14.6% according to the National Institute
of Health, Androgen Excess Society criteria, and
the Rotterdam consensus, respectively (1, 2).
This syndrome is associated with a range
of reproductive, endocrine, and metabolic
specifications, including obesity, being overweight,
hyperandrogenism, anovulation, and infertility that
results in hyperinsulinism and type II diabetes.
There are numerous researches about
inflammation in chronic diseases such as
PCOS, and the inflammatory markers include
C-reactive (CRP) protein, interleukin (IL) 6, and
tumor necrosis factor alpha (TNF-α). As a result
of inflammation, the risk of developing type
2 diabetes, cardiovascular disease, ovarian
dysfunction, and hyperandrogenism increases
because of the free radicals. Furthermore,
oxidative damage is aggravated by the decrease in
the body’s antioxidant defense mechanisms such
as superoxide dismutase (SOD) and catalase (CAT)
activities that act as free radicals’ scavengers. Total
antioxidant capacity (TAC) is sensitive to changes
in plasma antioxidant levels and degree of insulin
resistance. Therefore, a wide range of oxidative
stress biomarkers, including malondialdehyde
(MDA), protein carbonyl, TAC, SOD, glutathione
peroxidase (GPx), and glutathione (GSH) have
been tested in the patients (2-4).
Due to the low efficacy and safety of the
synthetic drugs and the increased risk of insulin
resistance and hyperlipidemia, there is a growing
tendency toward the consumption of medicinal
plants instead of synthetic compounds (5).
B. integerrima is a regular ingredient of Iranian
cuisine (6). The high antioxidant capacity of this
plant is because of the presence of natural
flavonoids and phenolic compounds such as
anthocyanins and carotenoids in Berberis which
are known to be antidiabetic, anticancer, and
antimicrobial natural agents. Research on the
cytotoxicity of B. integerrima extract demonstrated
no cellular toxicity (7-9).
Resveratrol (3, 5, 4’-trihydroxy-trans-stilbene)
is commonly found in grapes, peanuts, and
some types of berries as a natural polyphenolic
compound. It is recognized as a powerful
antioxidant with antiplatelet, anticancer, anti-
inflammation, and antiaging effects. Several
studies have demonstrated direct antioxidant
effects of resveratrol, and its protective effects may
be due to the enhancement of antioxidant capacity
in both humans and rodents (10, 11). As a result,
antioxidants are extremely important because they
inactivate the reactive species and increase the
protection of biological sites (9).
In this study, the effectiveness of resveratrol, B.
integerrima, and their combination were evaluated
in the PCOS rat models for the first time. Moreover,
the biochemical parameters, including oxidative
stress, inflammatory and lipid profiles, as well as
ovarian pathology were determined.
2. Materials and Methods
2.1. Induction of PCOS
Seventy adult female Sprague-Dawley rats aged
10-12 wk weighing 200 ± 20 gr were used in this
experimental study. The rats were kept ad libitum
in steel cages with controlled temperature and
humidity, 22 ± 2-C and 55 ± 5%, respectively, at 12
hr light/dark cycle. Letrozole orally induced PCOS
in rats; this model has histological and biochemical
similarities with PCOS in humans. This was done by
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inducing 1 mg/kg letrozole (Aburaihan Pharma.co.,
Tehran, Iran)dissolved in 0.9% NaCl solution (Razi
Pharma.co., Tehran, Iran) administered orally for 21
days (12). The flowchart of the study is shown in
Figure 1.
2.2. Experimental design
The rats were randomly divided into seven
groups (n = 10/ each) as follows:
•Group (I): control, healthy rats not receiving any
interventions;
• Group (II): vehicle, healthy rats receiving 1 cc
normal saline for 63 days;
• Group (III): letrozole-induced PCOS (Aburaihan
Pharma.co., Tehran, Iran), rats receiving 1 cc normal
saline for 42 days orally;
• Group (IV): PCOS + receiving 150 mg/kg
metformin (Shafa Pharma.co., Tehran, Iran)
dissolved in 1 cc normal saline for 42 days orally,
after letrozole-induced PCOS (13);
• Group (V): PCOS + receiving 20 mg/kg
resveratrol (Nutrivit Co., USA) dissolved in 1 cc
normal saline for 42 days orally, after letrozole-
induced PCOS (11);
• Group (VI): PCOS + 3 gr/kg barberry dissolved
in 1 cc normal saline for 42 days orally, after
letrozole-induced PCOS (14);
• Group (VII): PCOS + receiving 3 gr/kg barberry
and 20 mg/kg resveratrol dissolved in 1 cc normal
saline for 42 days orally, after letrozole-induced
PCOS.
All animals were weighed on day 1, after PCOS
induction (day 21), and at the end of the study (day
63). After 63 days, all study groups were made to
fast overnight and were anesthetized via ketamine
(Alfasan.co., Holland) (100 mg/kg) and xylazine
(Alfasan.co., Holland) (10 mg/kg). Blood samples
were collected by cardiocentesis, and their sera
were separated to be used for the assessment
of biochemical parameters. Afterward, the animals
were sacrificed and their ovaries were harvested,
cleaned of fat, weighed, and fixed in 10% formalin.
2.3. Barberry extract preparation
To prepare the extract, powdered fruit of B.
integerrima (herbarium number 2518) was mixed
with 70% ethanol (Razi Pharma.co., Tehran, Iran),
stirred for 72 hr, and placed in a percolator. The
remainders were placed in rotary devices and dried
in a vacuum in color glass until usage.
2.4. Antioxidant activity
2, 2-diphenyl-1-picrylhy-drazyl (DPPH) assay is a
powerful technique to determine the scavenging
potential of antioxidant. DPPH is characterized
as a stable radical containing the delocalization
electron with deep violet color (15). The odd
electron of DPPH absorbed a hydrogen atom from
antioxidants and the reduction of violet color took
place. The antioxidant capacity was calculated by
measuring the reduction in the absorbance at 517
nm. Themodified Brand-Williamsmethod has been
used in this study (16). Plants extract was diluted
with methanol at various concentrations. Quercetin
as a positive control was used. A stock solution of
DPPH (110 μM) was prepared freshly by dissolving
the appropriate amount in methanol. A volume of
20 μl of different concentrations of the sample
extract or standard liquid and 180 μl of methanol
(with or without DPPH) were mixed in 96-well plate
at 25°C temperature for 30 min (17).
The DPPH scavenging effect was calculated as
follows:
Scavenging effect (%) =
𝐴0 − 𝐴1
𝐴0 × 100
Where A0 is the absorbance of the control,
and A1 is the absorbance in the presence of
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the sample. All determinations were performed in
triplicate.
2.5. Determination of total phenolic
content (TPC) by Folin-Ciocalteu assay
Based on the Folin-Ciocalteu method, 10
μL of Folin-Ciocalteu reagent and 5 μL of the
tested sample or gallic acid as standard were
added to 96-well plate and diluted with 160
μL distilled water. The contents were then
mixed thoroughly for around 10 min. After 10
min of incubation, 30 μL of 25% Na2CO3 was
added and the mixture was further incubated
for 90 min at room temperature in the dark.
Finally, the absorbance was measured at
725 nm (18) and the concentration of the
total phenolic was calculated as milligrams
of gallic acid equivalents per gram of dry
extract.
2.6. Biochemical markers
Fasting blood glucose (FBG) was measured
by an enzymatic colorimetric method using a
biochemical Auto-analyzer (BT-1500, Italy) and
a commercial diagnostic kit (Pars Azmoon Co.,
Iran).
Lipid profiles [total cholesterol (TC), triglyceride
(TG), low-density lipoprotein (LDL), and high-
density lipoprotein (HDL)] were estimated
via the enzymatic colorimetric method
using a biochemical Auto-analyzer (BT-
1500, Italy) and the kits (Pars Azmoon Co.,
Iran).
SOD and TAC were determined via the
enzymatic colorimetric method with the
microplate reader using enzymatic kits (ZV-
TAC-A96) purchased from Zellbio Co., Germany.
Additionally, MDA activity was determined via
spectrophotometric analysis using thiobarbituric
acid reactive substances (TBARS) method
(19).
Plasma insulin level was measured via enzyme-
linked immunosorbent assay (ELISA) method
using insulin kits (Rat Insulin Mercodia 10-1250-01,
Sweden) (2).
The homeostasis model assessment of insulin




𝑚𝐿) × fasting plasma glucose (mM)
22.5
TNF-α was measured by the ELISA method
using TNF-α kits (865.000.96 Diaclone, France)
(21).
2.7. Ovarian histopathology
Consecutive serial sections with 5-micron
thickness from formalin-fix ovary were prepared,
and then from each 10 sections one slide
and from each ovarian sample 3 sections
were stained with hematoxylin and eosin
(22). The thin sections were dehydrated,
cleared, and eventually mounted within
Entellan® (Merck Co., Germany) and cover
slipped. The prepared slides were evaluated
using a light microscope (Olympus CX31,
Japan).
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Animal (n = 70) and 
experimental design 
(Control) normal healthy 
rats 
(Resveratrol + Berberis) letrozole–
induced rats receiving 20 mg/kg 
resveratrol and 3gr/kg berberis for 
42 days 
(Berberis) letrozole-induced 
rats receiving 3 gr/kg 
berberis for 42 days 
(Vehicle) healthy rats 
receiving 1 cc normal 
saline for 63 days 
(Metformin) letrozole induced rats 
receiving 150 mg/kg metformin for 
42 days 
(Resveratrol) letrozole-induced rats 
receiving 20 mg/kg resveratrol for 42 
days 
(PCOS) letrozole-induced rats 
receiving 1 cc normal saline for 
42 days 
Body weight of rats measured 
and anesthetized 
Ovarian tissue collected and 
measured 













Figure 1. Flow chart of the experimental design. PCOS Polycystic ovary syndrome; MDA, Malondialdehyde; TAC: Total antioxidant
capacity; SOD: Superoxide dismutase; TNF-α: Tumor necrosis factor alpha; LDL: Low-density lipoprotein; HDL: High-density
lipoprotein; TG: Triglyceride.
2.8. Ethical consideration
The study was conducted in accordance with
the recommendations of the European Council
Directive (86/609/EEC) on November 24, 1986,
regarding the protection of animals used for
experimental purposes (http://data.europa.eu/eli/
dir/1986/609/oj). The animal protocols were also
approved by the Ethics Committee of Shiraz
University of Medical Sciences, Shiraz, Iran (Code:
IR. SUMS. REC.1394.S1208).
2.9. Statistical analysis
The results have been reported as mean
± standard deviation. Additionally, data were
analyzed using one-way analysis of variance
(ANOVA) followed by Tukey’s test. P < 0.05
was considered to be statistically significant. All
analyses were done using the SPSS statistical




According to Table I, the PCOS-induced
group caused significant changes in serum lipid
levels compared to the controls. Additionally,
TG, TC, and LDL levels meaningfully increased
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(p = 0.02, p = 0.01, and p = 0.01, respectively),
while the HDL level decreased significantly
(p = 0.01) compared to the controls. However,
metformin, barberry, and resveratrol significantly
reduced TG (p = 0.01), TC (p = 0.01), and LDL
(p = 0.01) levels compared to the group with
PCOS. Nevertheless, the results showed no
significant changes between the barberry +
resveratrol rats and resveratrol, and barberry
groups related to the levels of HDL, LDL,
TC, and TG (p ≤ 0.05). There was no
significant difference between the treatment
groups.
The effects of barberry and resveratrol on
antioxidant activity and inflammatory factors
are presented in Figure 2. Accordingly, the
PCOS-induced group (without treatment)
showed a significant decrease in SOD
(p = 0.01) and TAC (p = 0.04) levels, but
an increase in TNFα (p = 0.01) and MDA
(p = 0.01) concentrations. Treatment with
metformin, resveratrol, and barberry could
restore SOD (p = 0.01) and TAC (p = 0.01)
levels close to those in the control groups.
However, MDA (p = 0.01) and TNF-α (p = 0.02)
levels reduced significantly in metformin-,
resveratrol-, and barberry-treated groups in
comparison to the control groups. Nonetheless,
no significant differences between the
barberry + resveratrol rats and those in the
resveratrol and barberry groups related to
MDA, SOD, TNF-α, and TAC concentrations
(p = 0.99) were observed. There was no
significant difference between the treatment
groups.
Table II shows the ovarian weights of rats in
the control and experimental groups. The ovarian
weight increased significantly in the PCOS rats
in comparison to the control rats (p = 0.01).
Treatment with metformin, barberry, resveratrol,
and barberry + resveratrol significantly decreased
the ovarian weight in PCOS rats after 42 days (p
= 0.01). The ovarian weights were not significant
between the barberry + resveratrol rats and
those in the resveratrol and barberry groups (p =
0.99).
3.2. Insulin resistance
According to the results presented in
Table II, the insulin level and HOMA-IR
score significant changes in the metformin-
, resveratrol-, and barberry-treated groups
compared to the control groups (p = 0.007, p
= 0.004, respectively) demonstrated significant
differences. The results also demonstrated no
significant differences between the barberry
+ resveratrol rats and those in resveratrol
and barberry groups with respect to insulin
level, glucose level, and HOMA-IR score (p =
0.99).
3.3. Histomorphological changes
In this study, a significant decrease in the
number of preantral follicles, antral follicles,
graafian follicles, and corpus luteum in PCOS
group compared to the control and vehicle
(p = 0.01) groups is observed (Figure 3A-D).
On the other hand, the number of follicles
increased significantly in comparison with
PCOS (p = 0.01). The number of atretic
and cystic follicles increased significantly
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in the PCOS group in contrast with the
control and vehicle groups; while, on the
other hand, they decreased significantly in
barberry, resveratrol and their combination
groups (p = 0.01) (Figure 3E-F). Ovarian
sections of control group animals exhibited
healthy follicles with oocytes at different
development stages (Figure 4A). PCOS-
induced group exhibited numerous subcapsular
cysts with very thin or no granulosa layers.
Additionally, complete absence of corpora
lutea were noticed, representing anovulation.
Few follicles were observed at their early
stages of development. In addition, they were
accompanied by atretic follicles containing
fluid-filled antrum and a larger number of
pyknotic granulosa cells (Figure 4B). On the
other hand, metformin treatment group led
to the removal of the cysts and appearance
of healthy follicles and corpora lutea (Figure
4C). Sections of the resveratrol (20 mg/kg)
group exhibited larger follicles and few corpora
lutea. Indeed, the cysts were absent and
normal-sized healthy follicles were found
at different development stages (Figure
4D). Photomicrograph from the barberry
group revealed an increase in this group’s
corpus luteum (Figure 4E). Treatment with
barberry and resveratrol also resulted in
the appearance of many corpora lutea and
antral follicles with clearly differentiated
oocytes, granulosa cell layers, corona radiates,
cumulus oophorus, and theca cells (Figure
4F).
3.4. Determination of TPC and
antioxidant activity
The DPPH antioxidant assay was performed to
determine the ability of the sample to inactivate
DPPH radical. The IC50 of Berberis hydroalcholic
extract and Quercetin as positive control were 33.1
± 1.07 μg/mL and 9.43 ± 2.26 μM, respectively.
The TPC of the extract as determined by Folin-
Ciocalteu method are reported as gallic acid
equivalent. As expected, the amount of total
phenolic compounds was found to be rich in
Berberis hydroalcoholic extract (214.12 ± 6.95 mg
GAE/gr dry extract). Values were expressed as
mean ± standard error of mean (SEM) of triplicate
experiments.
Table I. Measurements of lipid profiles in different groups
Groups LDL (mg/dl) HDL (mg/dl) TG (mg/dl) Cholesterol (mg/dl)
Control 83.35 ± 3.43 45.40 ± 2.96 78.86 ± 4.66 115.2 ± 2.67
Vehicle 85.26 ± 4.10 44.20 ± 1.93 81.22 ± 7.09 114.3 ± 2.77
PCOS 114.7 ± 4.15† 31.50 ± 2.00† 111.43 ± 8.04† 131.6 ± 3.11†
PCOS + Met 91.80 ± 2.74∗ 38.10 ± 2.66 75.56 ± 7.31∗ 111.2 ± 4.44∗
PCOS + Rez 93.25 ± 2.87∗ 41.90 ± 2.30 81.50 ± 3.67∗ 118.6 ± 2.49
PCOS + berberis 93.57 ± 1.85∗ 36.40 ± 2.39 78.78 ± 6.42∗ 113.8 ± 2.60∗
PCOS + Rez + berberis 92.64 ± 1.75∗ 44.40 ± 3.06∗ 73.89 ± 5.71∗ 114.6 ± 3.98∗
PCOS: Polycystic ovary syndrome;Met: Metformin; Rez: Resveratrol; LDL: Low-density lipoprotein; HDL: High density lipoprotein;
TG: Triglyceride, Data presented as Mean ± SD
†p < 0.05, PCOS vs. control and vehicle groups; *P < 0.05, PCOS group vs. PCOS + Met, PCOS + Rez
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Table II. Measurements of insulin and glucose concentrations, HOMA-IR score, and ovarian weight in different groups
Groups Ovarian weight (mg) Insulin (μu/ml) Glucose (mmol/L) HOMA-IR
Control 0.021 ± 0.001 9.85 ± 1.71 5.89 ± 0.49 2.58 ± 0.38
Vehicle 0.020 ± 0.001 8.78 ± 2.16 6.36 ± 0.36 2.48 ± 0.63
PCOS 0.045 ± 0.002† 20.47 ± 4.58† 6.49 ± 0.41 5.90 ± 1.49†
PCOS + Met 0.024 ± 0.002∗ 10.41 ± 1.43∗ 6.13 ± 0.68 2.84 ± 0.72∗
PCOS + Rez 0.028 ± 0.001∗ 10.57 ± 1.76∗ 6.69 ± 0.34 3.15 ± 1.08∗
PCOS + berberis 0.029 ± 0.002∗ 8.68 ± 1.53∗ 6.10 ± 0.32 2.36 ± 0.23∗
PCOS + Rez + berberis 0.026 ± 0.001∗ 9.47 ± 1.78∗ 5.94 ± 0.26 2.50 ± 0.88∗
Data presented as Mean ± SD
PCOS: Polycystic ovary syndrome; Met: Metformin; Rez: Resveratrol Homa-IR: Homeostatic model assessment for insulin
resistance
†p < 0.05, PCOS vs. control and vehicle groups; *p < 0.05 PCOS group vs. PCOS + Met, PCOS + Rez, PCOS + berberis, and
PCOS + Rez + berberis groups
Figure 2. The measurement of antioxidant activities and inflammatory factor in different groups.
PCOS: Polycystic ovary syndrome; Met: Metformin; Rez: Resveratrol; MDA: Malondialdehyde; TNF-α: Tumor necrosis factor-α;
SOD: Superoxide dismutase; TAC: Total antioxidant capacity
†p < 0.05, PCOS vs control and vehicle groups; *p < 0.05, PCOS vs PCOS + Met, PCOS + Rez, PCOS + berberis, and PCOS + Rez
+ berberis groups
*p < 0.05, †p < 0.05, **p < 0.01, ††p < 0.01, ***p < 0.001, †††p < 0.001
Page 644 https://doi.org/10.18502/ijrm.v13i8.7505
International Journal of Reproductive BioMedicine Healing efficacy of B. integerrima and resveratrol on PCOs rats
Figure 3. Presentation of the follicle numbers in different groups.
PCOS: Polycystic ovary syndrome; Met: Metformin; Rez: Resveratrol
A: Preantral follicles; B: Antral follicles; C: Graffian follicles; D: Corpus luteum; E: Atrelic follicles; F: Cystic follicles
†p < 0.05, PCOS vs control and vehicle groups; *p < 0.05, PCOS vs PCOS + Met, PCOS + Rez, PCOS + berberis, and PCOS + Rez
+ berberis groups, *p < 0.05, †p < 0.05, **p < 0.01, ††p < 0.01, ***p < 0.001, †††p < 0.001
https://doi.org/10.18502/ijrm.v13i8.7505 Page 645
International Journal of Reproductive BioMedicine Ashkar et al.
Figure 4. Images of ovaries in different stages of the intervention. (Magnification ×100). (A) Control group. (B) PCOs group. (C)
PCOS + metformin group. (D) PCOS + resveratrol group. (E) PCOS + barberry group. (F) PCOS + resveratrol + barberry group. The
arrows in A, D, E, and F indicate normal antral follicles. The red stars in B indicate ovarian cysts. The black stars in A, C, D, E, and
F indicate corpus luteum, and pick arrow in D indicate preantral follicles.
4. Discussion
Generally, the animal models are used to gain
clinical insight and high degree of evolutionary
conservation into human reproductive disorders,
especially PCOS (23). PCOS induced by letrozole is
histologically and biochemically similar to PCOS in
humans that increases testosterone but decreases
progesterone and estrogen levels, eventually
leading to the appearance of cysts that inhibit
the aromatase enzyme (24). Based on Webber
and colleagues study in 2003, PCOS could
result in an increase in the number of antral
follicles, ovarian stroma, hyperplasia theca cells,
and ovarian cortical thickness (25). Moreover, it
can be concluded that the number of primordial
and primary forms of prenatal follicles is increased
in PCOS compared with normal ovaries. Indeed,
the number of primary follicles (early growing)
is increased significantly in both ovulatory and
anovulatory PCOS, with a reciprocal decrease in
the proportion of primordial follicles compared to
normal ovaries. These results are in line with those
of the present investigation.
The histomorphological slides in the resveratrol
group showed fewer cysts and the presence of
corpus luteum in the ovaries, indicating follicle
maturation and ovulation. This was in the same
line with the results of a previous study by
Ergenoglu and co-workers In that study, the
treatment of PCOS-induced rats with 10 mg/kg
resveratrol led to the development of antral
follicles to the normal state (11). These favorable
changes indicate that barberry, resveratrol,
and their combination may have positive
effects on PCOS symptoms. Interestingly, the
histomorphological changes in the barberry,
resveratrol, and their combination groups were
totally comparable to those in the metformin-
treated group.
In this study, it was found that B. integerrima is
a predominant source of antioxidant (DPPH, assay,
IC50 = 33.1 + 1.07 µg/mL). Our data are supported
by a few investigations on antioxidant activity and
phenolic content amounts of Berberis species (26-
28). High amounts of antioxidant and polyphenol
present in Berberis act as free radical scavengers,
making it a necessary aid to human health.
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Our results revealed a significant increase
in body weight among the rats suffering from
letrozole-induced PCOS in comparison with the
control and vehicle groups, which was consistent
with the results obtained by Maharjan (29). On the
other hand, our findings confirmed that there is a
significant decrease in body weight in the groups
treated with barberry, metformin, and resveratrol.
These effects are consistent with the previously
published data.
Evidence indicate that there is an excessive
occurrence of alterations in lipid profiles and
lipedema in women with PCOS (30). The
current results demonstrated that barberry
extract and resveratrol could reduce TC, LDL,
and TG levels following an increase in HDL
concentrations. Besides, the simultaneous use of
barberry and resveratrol provides better results in
comparison with metformin in terms of HDL and
TG concentration.
Recent studies have shown that Peroxisome
proliferation-activated receptor-α (PPAR-α) is
predominantly expressed in tissues that have
fatty acids metabolizing function such as liver,
heart, kidney, and muscles. Activation of PPAR-
α could reduce serum TG and also raise HDL
level. Barberry is able to activate PPAR-α and
AMP-activated protein kinase (AMPK) which is
accompanied by reduction of lipid accumulation in
adipocytes (31). Similarly, Derosa and colleagues
examined the potential application of Berberine
in the regulation of plasma lipids in patients
with cardiovascular diseases and found that
Berberine present in barberry could decrease TC,
LDL, and TG levels following an increase in HDL
concentration (32).
Another study found that Berberine might
improve the liver function and secretion of bile
acids. It seems that the high levels of polyphenolic
compounds might inhibit intestinal cholesterol
absorption, inactivate 3-hydroxy-3-methyl-glutaryl-
CoA reductase (HMGCoA) enzyme, and reduce the
intestinal production of chylomicrons in berberine
which in turn results in constructive effects of this
substance on lipid profiles (33).
The hypocholesterolemia-inducing effect of
resveratrol may be explained by its phenolic
hydroxyls compounds that result in oxidation of
unsaturated fatty acids, as well as a decrease
in circulating cholesterol, downregulation of
HMG-CoA reductase, and an increase in the
expression of the LDL receptors (LDL-R) in
hepatocytes. In addition, it is reported that the
alternations in medium and long-chain triglyceride
concentrations, decreased apolipoprotein C-III,
reduced activity of hepatic acyl-CoA cholesterol
acyltransferase, and the upregulation of genes
involved in lipid metabolism might be linked to the
hypotriglyceridemic effect of resveratrol which is
in line with our findings (34-36).
A clinical trial demonstrated that 250-1000 mg
daily consumption of resveratrol declined LDL in
patients with type II diabetes. In the same way,
treatment with resveratrol (150 mg daily) lowered
plasma TG in healthy obese men (37).
It was previously reported by Victor and
colleagues that changes in the mitochondrial
membrane potentially resulted in the activation
of kappa B nuclear factor ( a pro-inflammatory
transcription factor) that induces reactive oxygen
species (ROS) , TNF-α, and endothelial dysfunction
in patients with PCOS (38). Although, TNF-
α could increase the inflammatory factors
such as IL-1, IL-6, and inducible nitric oxide
synthase, resveratrol might play an essential
role in inhibiting the expression of inflammatory
factors (39). A number of studies showed that
resveratrol could decrease TNF-α concentration
and improve SOD and glutathione peroxidase 1
levels, in addition to disabling superoxide and
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hydrogen peroxide which is in correlation with the
findings of the present study (40, 41). A number of
studies suggested that Berberine exerts its anti-
inflammatory effects by inhibiting cyclooxygenase-
2, which is an enzyme that is responsible for
inflammation, as well as nuclear factor kappa-
light-chain-enhancer of activated B cells. In
this way, it directly scavenges superoxide-free
radicals in the system, increases the expression
of sirtuin 1, and decreases oxidative stress by
reducing expression of nicotinamide and adenine
dinucleotide phosphate oxidase which are critical
sources for ROS production in cells. In line with the
present research, the review study performed by
Imenshahidi and co-workers showed that barberry
and resveratrol might suppress TNF-α, IL-1, nitric
oxide (NO), and MDA through the aforementioned
mechanism (9, 19, 42, 43). According to this
mechanism, resveratrol and barberry increase
SOD and TAC levels. As a result, the simultaneous
consumption of barberry and resveratrol increased
the antioxidant activity and significantly reduced
the inflammation in the PCOS group compared
with the metformin group at TAC level. In other
words, the simultaneous consumption of barberry
and resveratrol led to more desirable results
possibly due to their synergistic effects.
The high prevalence of abnormal blood sugar
levels in PCOS patients indicates the presence
of deficiencies in insulin secretion as well as its
function. One study found that androgens could
cause insulin resistance and change insulin action
in the target tissues in PCOS patients, which may
eventually increase visceral adiposity and reduce
the secretion of adiponectin, which is the major
insulin-sensitizing adipokine (44).
According to the studies, resveratrol and
barberry might reduce insulin resistance by
regulating insulin signaling pathway through
increasing protein kinase B (PKB) expression.
This is following the increase in the activity of
peroxisome proliferator-activated receptor-gamma
(PPAR-γ) and expression of glucose transporter
type 4, sirtuin 1, and enhancing glucose uptake in
the absence of insulin. In addition, the inhibition of
insulin secretion from new island cells, reducing
intestinal glucose absorption by inhibiting α-
glucosidase activity, and stimulating healthy
pancreatic beta cells are other results of this
pathway. A study has discovered that berberine
reduces insulin resistance in metabolic syndrome
(45-47).
The results of this study revealed that the
administration of barberry extract and resveratrol in
adult female rats with PCOs can lead to significant
changes in their insulin resistance.
However, there were no significant changes in
the serum glucose levels. This might be a result of
low antioxidant dosages and short study duration.
5. Conclusion
In conclusion, it can be stated that the
combination of Resveratrol and B. integerrima
(as natural products) can decrease biochemical
factors related to the pathogenesis of PCOS.
They have the promising antioxidant capacity and
anti-inflammatory activities that might ameliorate
the complications, and they might be able to
regenerate the ovarian morphology to the normal
state. Future studies in larger groups, as well
as randomized clinical trials on resveratrol and
barberry, will help researchers in introducing new
treatments for PCOS patients.
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